AINDEX
Markets

Avantor, Inc. (AVTR)

AVTRNYSEBiotechnology: Laboratory Analytical Instruments

$15.32

-0.2200 (-1.42%) today

Closed, Nov 16, 4:00 PM ET

-1.42% 1D
Market cap
$10.39bn
P/E
18.7
EPS, last 4 quarters
$0.8200
Dividend yield
–
Day range
–
52-week range
$7.27 to $17.45
Average volume
–
Previous close
$15.54

Analysts

13 covering

Hold1 buy, 11 hold, 1 sell

Targets a year out average $16.73, +9.2% from here

$15.00now $15.32$18.00

Earnings

next estimate $0.2200

Next report

Dec 2025

+4.8%

Mar 2026

+6.3%

Jun 2026

+10.5%

Sep 2026

+4.8%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.66bn$1.58bn$1.69bn$1.70bn
Gross profit$523.90m$500.70m$537.00m$534.80m
Operating income$126.40m$99.50m$121.80m$139.50m
Net income$52.40m$43.30m$38.10m$203.40m

Last four quarters: revenue $6.64bn, margin 5.1%, free cash flow $439.20m

News

8 latest

The company

Avantor is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Avantor, Inc. (AVTR) price, chart and news · AINDEX